Carl Dambkowski sold $307K of Apogee Therapeutics (APGE)

Executed Dec 4 2024, disclosed Dec 6 2024, 2 days later.

Value, as filed

$307K

6,665 sh × $46.07

Executed

Dec 4 2024

the trade date, as filed

Disclosed

Dec 6 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Carl Dambkowski Director profile →

Carl Dambkowski (Director) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $6.2M of ORKA (105,000 sh across 3 lots, as filed), executed May 21.

The name

APGE

Apogee Therapeutics, Inc. APGE · Healthcare · 47 filings in 24 months ticker →

Healthcare · Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Carl Dambkowski in APGE

APGESALE Apogee Therapeutics, Inc. $738K
5,500 sh × $134.17
Exec Aug 5
Filed Aug 7 · 8:00 PM ET APGESALE Apogee Therapeutics, Inc. $730K
5,500 sh × $132.74
Exec Jul 1
Filed Jul 2 · 8:13 PM ET APGESALE Apogee Therapeutics, Inc. $3.5M
26,400 sh × $132.60
Exec Jun 22
Filed Jun 24 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $433K
5,500 sh × $78.71
Exec Jun 3
Filed Jun 5 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $463K
5,500 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $458K
5,400 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $376K
5,300 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. $161K
2,481 sh × $64.88
Exec Feb 4
Filed Feb 4 · 5:30 PM ET